Evidence map›Paper›PMID 26569479›Full record

Trial reportJAMA neurology2016

Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Laura Eisenmenger, Marie-Claire Porter, Christopher J Carswell, Andrew Thompson, Simon Mead, Peter Rudge, John Collinge, Sebastian Brandner, Hans R Jäger, Harpreet Hyare

Abstract readClinical Trial
In one paragraph

Trial report in JAMA neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cortical ribbon sign in AMPAR antibody-associated encephalitis mimicking Creutzfeldt-Jakob disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Current advances in neuronal intranuclear inclusion disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Laura EisenmengerDepartment of Radiology, University of Utah, Salt Lake City.
Marie-Claire PorterMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Christopher J CarswellMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Andrew ThompsonMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Simon MeadMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Peter RudgeMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
John CollingeMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Sebastian BrandnerMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
Hans R JägerLysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, England.
Harpreet HyareMedical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England.
MRC Prion Unit · GBUniversity of Utah · USMedical Research Council · GBUniversity College London · GB

Funding

Department of HealthMedical Research Council G0400713Medical Research Council MC_U123160651Medical Research Council MC_U123160657
6 · The paper itself

Abstract

importancePrion diseases represent the archetype of brain diseases caused by protein misfolding, with the most common subtype being sporadic Creutzfeldt-Jakob disease (sCJD), a rapidly progressive dementia. Diffusion-weighted imaging (DWI) has emerged as the most sensitive magnetic resonance imaging (MRI) sequence for the diagnosis of sCJD, but few studies have assessed the evolution of MRI signal as the disease progresses.

objectivesTo assess the natural history of the MRI signal abnormalities on DWI in sCJD to improve our understanding of the pathogenesis and to investigate the potential of DWI as a biomarker of disease progression, with histopathological correlation. DESIGN, SETTING, AND

participantsGray matter involvement on DWI was assessed among 37 patients with sCJD in 26 cortical and 5 subcortical subdivisions per hemisphere using a semiquantitative scoring system of 0 to 2 at baseline and follow-up. A total brain score was calculated as the summed scores in the individual regions. In 7 patients, serial mean diffusivity measurements were obtained. Age at baseline MRI, disease duration, atrophy, codon 129 methionine valine polymorphism, Medical Research Council Rating Scale score, and histopathological findings were documented. The study setting was the National Prion Clinic, London, England. All participants had a probable or definite diagnosis of sCJD and had at least 2 MRI studies performed during the course of their illness. The study dates were October 1, 2008 to April 1, 2012. The dates of our analysis were January 19 to April 20, 2012. MAIN OUTCOMES AND MEASURES: Correlation of regional and total brain scores with disease duration.

resultsAmong the 37 patients with sCJD in this study there was a significant increase in the number of regions demonstrating signal abnormality during the study period, with 59 of 62 regions showing increased signal intensity (SI) at follow-up, most substantially in the caudate and putamen (P < .001 for both). The increase in the mean (SD) total brain score from 30.2 (17.3) at baseline to 40.5 (20.6) at follow-up (P = .001) correlated with disease duration (r = 0.47, P = .003 at baseline and r = 0.35, P = .03 at follow-up), and the left frontal SI correlated with the degree of spongiosis (r = 0.64, P = .047). Decreased mean diffusivity in the left caudate at follow-up was seen (P < .001). Eight patients demonstrated decreased SI in cortical regions, including the left inferior temporal gyrus and the right lingual gyrus. CONCLUSIONS AND RELEVANCE: Magnetic resonance images in sCJD show increased extent and degree of SI on DWI that correlates with disease duration and the degree of spongiosis. Although cortical SI may fluctuate, increased basal ganglia SI is a consistent finding and is due to restricted diffusion. Diffusion-weighted imaging in the basal ganglia may provide a noninvasive biomarker in future therapeutic trials.

Indexed as

AdultAgedAged, 80 and overCreutzfeldt-Jakob SyndromeDiffusion Magnetic Resonance ImagingFemaleFollow-Up StudiesHumansMaleMiddle Aged

Identifiers

PMID26569479
PMCPMC5837002
OpenAlexW2175632660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.